In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regime...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6508e17c6fdd4f1a8cecab535185385a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6508e17c6fdd4f1a8cecab535185385a2021-12-02T14:38:53ZIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer10.1038/s41467-018-05742-z2041-1723https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05742-zhttps://doaj.org/toc/2041-1723Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regimens.Ivana ZagoracSara Fernandez-GaiteroRenske PenningHarm PostMaria J. BuenoSilvana MouronLuis MansoManuel M. MorenteSoledad AlonsoVioleta SerraJavier MuñozGonzalo Gómez-LópezJose Francisco Lopez-AcostaVeronica Jimenez-RenardAlbert Gris-OliverFatima Al-ShahrourElena Piñeiro-YañezJose Luis Montoya-SuarezJuan V. ApalaAmalia Moreno-TorresRamon ColomerAna DopazoAlbert J. R. HeckMaarten AltelaarMiguel Quintela-FandinoNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-15 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Ivana Zagorac Sara Fernandez-Gaitero Renske Penning Harm Post Maria J. Bueno Silvana Mouron Luis Manso Manuel M. Morente Soledad Alonso Violeta Serra Javier Muñoz Gonzalo Gómez-López Jose Francisco Lopez-Acosta Veronica Jimenez-Renard Albert Gris-Oliver Fatima Al-Shahrour Elena Piñeiro-Yañez Jose Luis Montoya-Suarez Juan V. Apala Amalia Moreno-Torres Ramon Colomer Ana Dopazo Albert J. R. Heck Maarten Altelaar Miguel Quintela-Fandino In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
description |
Triple-negative breast cancer (TNBC) lacks prognostic and predictive markers. Here, the authors use phosphoproteomics to define kinases with distinct activity profiles in TNBC, demonstrating their prognostic value as well as their utility for simplifying TNBC classification and designing drug regimens. |
format |
article |
author |
Ivana Zagorac Sara Fernandez-Gaitero Renske Penning Harm Post Maria J. Bueno Silvana Mouron Luis Manso Manuel M. Morente Soledad Alonso Violeta Serra Javier Muñoz Gonzalo Gómez-López Jose Francisco Lopez-Acosta Veronica Jimenez-Renard Albert Gris-Oliver Fatima Al-Shahrour Elena Piñeiro-Yañez Jose Luis Montoya-Suarez Juan V. Apala Amalia Moreno-Torres Ramon Colomer Ana Dopazo Albert J. R. Heck Maarten Altelaar Miguel Quintela-Fandino |
author_facet |
Ivana Zagorac Sara Fernandez-Gaitero Renske Penning Harm Post Maria J. Bueno Silvana Mouron Luis Manso Manuel M. Morente Soledad Alonso Violeta Serra Javier Muñoz Gonzalo Gómez-López Jose Francisco Lopez-Acosta Veronica Jimenez-Renard Albert Gris-Oliver Fatima Al-Shahrour Elena Piñeiro-Yañez Jose Luis Montoya-Suarez Juan V. Apala Amalia Moreno-Torres Ramon Colomer Ana Dopazo Albert J. R. Heck Maarten Altelaar Miguel Quintela-Fandino |
author_sort |
Ivana Zagorac |
title |
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
title_short |
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
title_full |
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
title_fullStr |
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
title_full_unstemmed |
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
title_sort |
in vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/6508e17c6fdd4f1a8cecab535185385a |
work_keys_str_mv |
AT ivanazagorac invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT sarafernandezgaitero invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT renskepenning invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT harmpost invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT mariajbueno invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT silvanamouron invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT luismanso invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT manuelmmorente invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT soledadalonso invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT violetaserra invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT javiermunoz invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT gonzalogomezlopez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT josefranciscolopezacosta invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT veronicajimenezrenard invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT albertgrisoliver invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT fatimaalshahrour invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT elenapineiroyanez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT joseluismontoyasuarez invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT juanvapala invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT amaliamorenotorres invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT ramoncolomer invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT anadopazo invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT albertjrheck invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT maartenaltelaar invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer AT miguelquintelafandino invivophosphoproteomicsrevealskinaseactivityprofilesthatpredicttreatmentoutcomeintriplenegativebreastcancer |
_version_ |
1718390837537144832 |